Jul 2026· International journal for development of science and technology· Vol 2, pp. 1-12· 0 citations
TL;DR
A review of nanoparticle-based drug delivery systems highlights key design principles, explores mechanisms underlying controlled and targeted delivery, and discusses the growing importance of smart polymeric systems in the evolving field of nanomedicine.
Abstract
The development of nanoparticle-based drug delivery systems represents a major step forward in pharmaceutical science, with the goal of enhancing treatment effectiveness while ensuring patient safety. Among these systems, polymeric nanoparticles-especially those made from biodegradable materials-have gained considerable interest due to their biocompatibility and versatile structural properties. Through careful formulation approaches, including surface modification, appropriate polymer selection, and optimization of physicochemical properties, these carriers can achieve sustained and controlled drug release. Such controlled release helps maintain stable drug levels in the bloodstream, reduces dosing frequency, and minimizes adverse effects. Furthermore, incorporating targeting strategies allows for more precise drug delivery by promoting accumulation at specific sites of action. In addition, advanced stimuli-responsive systems introduce an extra level of regulation, enabling drug release in response to specific biological triggers like pH changes, temperature variations, or enzymatic activity. This review highlights key design principles, explores mechanisms underlying controlled and targeted delivery, and discusses the growing importance of smart polymeric systems in the evolving field of nanomedicine.
This review comprehensively examines major nanocarrier platforms, including lipid-based, polymeric, inorganic, and hybrid systems, with emphasis on their structural design and functional properties.
Nithya Ajay, Anu Shibi Anilkumar, R. Veerabathiran· Therapeutic delivery· 0 citations
The review gives a general description of drug delivery systems that are based on nanotechnology, with liposomes, polymeric nanoparticles, dendrimers, solid lipid nanoparticles, and metallic nanoparticles being the main examples of nanocarriers.
Shalini Tiwari, S. Kotnala, Rohinee Bhandari et al.· Trends in Biomaterials & Art...· 0 citations
Overall, this review shows that nanofiber-based drug delivery systems have significant advantages over conventional dosage forms and demonstrate considerable potential for next-generation therapies and pharmaceutical products with systematic formulation optimization, standardized characterization protocols, and clinica...
P. S. Patil, P. Pawar· Current Nanomaterials· 0 citations
This review critically evaluates recent progress from 2022 to 2025 in three major technological approaches: solid dispersions, lipid-based formulations, and nanotechnology-enabled drug delivery systems, and evolving regulatory landscape for complex and nanotechnology-based formulations.
R. Srivastava, C. K. Gupta· Journal of Pharmaceutical Re...· 0 citations
This review highlights MSN-based drug delivery systems in cancer therapy, where multifunctional nanocarriers enable site-specific delivery, controlled drug release, enhanced tumor accumulation, and reduced off-target effects.
Manickam Rajkumar, N. Prathap, V. Kashid et al.· Pharmaceutics· 0 citations
This review primarily summarizes individual carrier systems, preparation methods, release mechanisms, and biomedical applications into a unified framework while identifying current limitations related to nanoparticle aggregation, long-term biocompatibility, biodegradation, large-scale manufacturing, regulatory approval...
M. Samy· Kompleksnoe Ispolzovanie Min...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.